Olink to report first quarter 2023 financial results on May 11, 2023
13. April 2023 08:00 ET
|
Olink Proteomics AB
UPPSALA, Sweden, April 13, 2023 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK) today announced it will release financial results for the first quarter of 2023 before the market...
Olink to report first quarter 2023 financial results on May 11, 2023
13. April 2023 08:00 ET
|
Olink Proteomics AB
UPPSALA, Sweden, April 13, 2023 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK) today announced it will release financial results for the first quarter of 2023 before the market...
Swedish Olink technology enables further development of South African research and innovation
29. März 2023 08:00 ET
|
Olink Proteomics AB
UPPSALA, Sweden, March 29, 2023 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (Nasdaq: OLK) today announced that the regional proteomic facility, D-CYPHR in Cape Town, South Africa has adopted Olink...
Swedish Olink technology enables further development of South African research and innovation
29. März 2023 08:00 ET
|
Olink Proteomics AB
Uppsala, Sweden, March 29, 2023 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (Nasdaq: OLK) today announced that the regional proteomic facility, D-CYPHR in Cape Town, South Africa has adopted Olink...
Olink publishes 2022 annual report
27. März 2023 07:30 ET
|
Olink Proteomics AB
UPPSALA, Sweden, March 27, 2023 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK) today announced that the Annual Report for 2022 is now available on the Company’s website at...
Bruno Rossi joins Olink as Chief Commercial Officer
21. März 2023 08:00 ET
|
Olink Proteomics AB
UPPSALA, Sweden, March 21, 2023 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK) today announced the appointment of life sciences industry veteran Bruno Rossi to the role of Chief...
Bruno Rossi joins Olink as Chief Commercial Officer
21. März 2023 08:00 ET
|
Olink Proteomics AB
UPPSALA, Sweden , March 21, 2023 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK) today announced the appointment of life sciences industry veteran Bruno Rossi to the role of...
Notice to attend the Annual General Meeting of Olink Holding AB (publ)
15. März 2023 16:05 ET
|
Olink Proteomics AB
UPPSALA, Sweden, March 15, 2023 (GLOBE NEWSWIRE) -- The shareholders of Olink Holding AB (publ) (the “Company” or “Olink”), reg. no. 559189-7755, are hereby given notice to attend the Annual General...
NUS Medicine implements Olink technology to accelerate precision medicine through next-generation proteomics
06. März 2023 08:00 ET
|
Olink Proteomics AB
Uppsala, Sweden, March 06, 2023 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (Nasdaq: OLK) today announced that the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine)...
NUS Medicine implements Olink technology to accelerate precision medicine through next-generation proteomics
06. März 2023 08:00 ET
|
Olink Proteomics AB
UPPSALA, Sweden, March 06, 2023 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (Nasdaq: OLK) today announced that the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine)...